Journal for ImmunoTherapy of Cancer (Jul 2020)
Correction: Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy
Abstract
No abstracts available.